Advancing Coverage with Policy & Payer Engagement
Speaker:
Jessie Conta, MS, CGC, Sarah Soto, MS CGC, Market Access Strategy, Abbott Cancer Diagnostics; Payor Coverage and Evidence Strategy, GeneDx
Contact Hours:
1.0
Date:
July 07, 2026 - July 31, 2027
Description:
Insurance coverage plays an important role in determining patient access to advanced genetic testing. This session explains why exome and genome sequencing coverage varies among payers, how evidence shapes medical policies, and current efforts to improve access for patients with rare diseases.
Learning Objectives:
- >
- Explain the current national landscape of ES/GS coverage
- Evaluate the evolution of coverage sample policies
- Identify successful strategies for payer engagement and outreach